← Leaderboards
David M Mahvi
University Of Wisconsin Madison
$2,677,871
Attributed
$2,677,871
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $556.3K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,677,871 · 4
By mechanism
R01$2,024,839 · 1
T32$378,300 · 1
M01$274,732 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Henry I Robins$703,981
- James A Stewart$6,121,809
- Nimmi Ramanujam$17,436,488
- Richard Reed Love$7,546,491
- Howard H Bailey$27,057,671
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectNeoplasm /Cancer TherapyHuman Therapy EvaluationNeoplastic CellMelanomaMetastasisModel Design /DevelopmentNeoplasm /Cancer ChemotherapyClinical ResearchGene TherapyNeoplasm /Cancer ThermotherapyNeoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer SurgeryBiosensor DevicePatient Oriented ResearchDisease /Disorder ModelTransfectionAutologous TransplantationClinical TrialsColony Stimulating FactorCryotherapyElectrodesHuman Genetic Material TagImmunocytochemistry
Grant awards (13)
Surgical Oncology Research Training Program$176,838
T32 · FY2007 · CA · contact PI
Surgical Oncology Research Training Program$52,809
T32 · FY2006 · CA · contact PI
HEPATIC RF ABLATION: DEVELOPMENT OF EFFECTIVE DEVICES$407,656
R01 · FY2005 · DK
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$148,653
T32 · FY2005 · CA
HEPATIC RF ABLATION: DEVELOPMENT OF EFFECTIVE DEVICES$395,782
R01 · FY2004 · DK
Treatment of Spontaneous Tumor Metastases with IL-12 DNA: A Phase IB Trial$35,822
M01 · FY2004 · RR
HEPATIC RF ABLATION: DEVELOPMENT OF EFFECTIVE DEVICES$384,252
R01 · FY2003 · DK
HEPATIC RF ABLATION: DEVELOPMENT OF EFFECTIVE DEVICES$403,020
R01 · FY2002 · DK
IMMUNIZATION WITH AUTOLOGOUS TUMOR CELLS TRANSFECTED WITH GM-CSF GENE BY PMT$106,600
M01 · FY2002 · RR
HEPATIC RF ABLATION: DEVELOPMENT OF EFFECTIVE DEVICES$434,129
R01 · FY2001 · DK
IMMUNIZATION WITH AUTOLOGOUS TUMOR CELLS TRANSFECTED WITH GM-CSF GENE BY PMT$106,600
M01 · FY2001 · RR
IMMUNIZATION WITH AUTOLOGOUS TUMOR CELLS TRANSFECTED WITH GM-CSF GENE BY PMT$12,855
M01 · FY2001 · RR
IMMUNIZATION WITH AUTOLOGOUS TUMOR CELLS TRANSFECTED WITH GM-CSF GENE BY PMT$12,855
M01 · FY2000 · RR